Arcutis Biotherapeuticsincis A Biopharmaceutical Company Based In Westlake Villagecaliforniafounded In 2016The Company Specializes In Developing Innovative Treatments For Immune Mediated Dermatological Diseaseswith A Team Experienced In Dermatology And Commercializationarcutis Has Contributed To The Development Of Over 50 Fda Approved Products The Company Focuses On Creating Meaningful Innovations In Medical Dermatologyguided By The Needs Of Patients And Healthcare Professionalsarcutis S Pipeline Includes Several Promising Treatmentssuch As Arq 151A Topical Cream For Immune Mediated Skin Diseasesand Arq 252A Jak1 Inhibitor For Various Conditions Including Psoriasis And Atopic Dermatitisother Products In Development Target Scalp Psoriasisalopecia Areataand Atopic Dermatitisarcutis Is Dedicated To Addressing The Challenges Faced In Dermatology Through Its Robust Pipeline Of Therapies
